Back to Bills
SENATE-BILL 3729119th Congress

SENATE-BILL 3729: S.3729 - PBM Reporting Transparency Act

Introduced: January 29, 2026
Status: Referred to Committee
supported

AI-Powered Summary

Generated by AI Analysis

SENATE-BILL 3729 aims to enhance transparency in prescription drug pricing within Medicare by mandating the Medicare Payment Advisory Commission (MedPAC) to report on agreements with pharmacy benefit managers (PBMs). The major themes addressed include healthcare access, drug pricing transparency, and the financial implications for Medicare enrollees. Key provisions require MedPAC to submit two reports to Congress: the first analyzing trends in out-of-pocket spending and the second assessing changes over time. The implementation timeline involves the submission of these reports, which are intended to inform future legislative actions. Potential impacts include increased transparency that may lead to lower costs for individuals, while also raising constitutional concerns regarding access to medications and the adequacy of protections for individual rights in the healthcare system.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill promotes transparency in healthcare, which is essential for informed decision-making and accountability. By mandating reports on PBM agreements, it seeks to protect individuals' rights to understand their healthcare costs and advocate for equitable access to medications.

Key Individual Rights Affected

  • Right to Information
  • Equal Protection under the 14th Amendment
  • Due Process under the 14th Amendment

Constitutional Provisions Most Relevant

  • 14th Amendment - Equal Protection Clause
  • 14th Amendment - Due Process Clause

Potential Constitutional Challenges Or Support

While the bill supports transparency and accountability, it may face challenges if it reveals disparities that disproportionately affect certain demographic groups, raising equal protection concerns. Additionally, there could be debates regarding the extent of congressional power in regulating healthcare markets.

Summary Of Bill Implications

The PBM Reporting Transparency Act aims to enhance individuals' understanding of healthcare costs, particularly for Medicare enrollees. By increasing transparency, it empowers individuals to make informed choices and advocate for their rights, while also highlighting potential disparities in access to medications among different demographic groups. The bill's focus on transparency aligns with constitutional principles, supporting the rights of individuals to equitable healthcare.

Constitutional Analysis

supported

This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention S. 3729 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Policy Topics

Timeline

January 29, 2026

Bill Introduced

Current

Referred to Committee

June 12, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat